SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Laurus Labs informs about update on acquisition of shares

21 Nov 2023 Evaluate

In continuation of its disclosures dated September 11, 2023 and October 16, 2023 regarding signing of SPAs with the shareholders of Laurus Bio for purchase of 37,641 equity shares through secondary purchase and partial completion of acquisition of 29,308 shares respectively. In this regard, Laurus Labs has informed that the Company has completed the acquisition of balance 8,333 equity shares from the promoter group shareholders of Laurus Bio on November 20, 2023. With this acquisition the Company holds 87.59% shareholding (on fully diluted basis) in Laurus Bio.

The above information is a part of company’s filings submitted to BSE.



Laurus Labs Share Price

1113.50 -15.30 (-1.36%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×